Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 16Leukemia, Myelomonocytic, Acute 11Leukemia, Monocytic, Acute 11Leukemia, Megakaryoblastic, Acute 11Leukemia, Erythroblastic, Acute 11Breast Neoplasms 9Congenital Abnormalities 8Glioblastoma 7Pancreatic Neoplasms 6Recurrence 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Eosinophilic, Acute 5Leukemia, Basophilic, Acute 5Leukemia 5Gliosarcoma 5Anemia, Refractory, with Excess of Blasts 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Carcinoma, Non-Small-Cell Lung 4Brain Neoplasms 4Blast Crisis 4Urinary Bladder Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 3Squamous Cell Carcinoma of Head and Neck 3Multiple Myeloma 3Lung Neoplasms 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Inflammatory Breast Neoplasms 3Head and Neck Neoplasms 3Breast Neoplasms, Male 3Thyroid Neoplasms 2

Interventions

tipifarnib 1peginterferon alfa-2b 1nilotinib 1mirdametinib 1binimetinib 1Vincristine 1Temozolomide 1Sirolimus 1Ranibizumab 1Radiosurgery 1Mn-PyC3A 1Imatinib Mesylate 1Everolimus 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neurofibroma × tipifarnib × Clear all
NCT00021541 2018-04-17

R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
62 enrolled 13 charts
CNS

Neurofibroma, Neurofibromatosis 1, Neurofibromatoses, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡